Literature DB >> 33495566

PRMT3 interacts with ALDH1A1 and regulates gene-expression by inhibiting retinoic acid signaling.

Mamta Verma1, Mohd Imran K Khan1, Rajashekar Varma Kadumuri2, Baskar Chakrapani1, Sharad Awasthi1, Arun Mahesh1, Gayathri Govindaraju3, Pavithra L Chavali4, Arumugam Rajavelu3, Sreenivas Chavali5, Arunkumar Dhayalan6.   

Abstract

Protein arginine methyltransferase 3 (PRMT3) regulates protein functions by introducing asymmetric dimethylation marks at the arginine residues in proteins. However, very little is known about the interaction partners of PRMT3 and their functional outcomes. Using yeast-two hybrid screening, we identified Retinal dehydrogenase 1 (ALDH1A1) as a potential interaction partner of PRMT3 and confirmed this interaction using different methods. ALDH1A1 regulates variety of cellular processes by catalyzing the conversion of retinaldehyde to retinoic acid. By molecular docking and site-directed mutagenesis, we identified the specific residues in the catalytic domain of PRMT3 that facilitate interaction with the C-terminal region of ALDH1A1. PRMT3 inhibits the enzymatic activity of ALDH1A1 and negatively regulates the expression of retinoic acid responsive genes in a methyltransferase activity independent manner. Our findings show that in addition to regulating protein functions by introducing methylation modifications, PRMT3 could also regulate global gene expression through protein-protein interactions.

Entities:  

Year:  2021        PMID: 33495566      PMCID: PMC7835222          DOI: 10.1038/s42003-020-01644-3

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  75 in total

1.  Predicting functionally important residues from sequence conservation.

Authors:  John A Capra; Mona Singh
Journal:  Bioinformatics       Date:  2007-05-22       Impact factor: 6.937

2.  Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons.

Authors:  Jae-Ick Kim; Subhashree Ganesan; Sarah X Luo; Yu-Wei Wu; Esther Park; Eric J Huang; Lu Chen; Jun B Ding
Journal:  Science       Date:  2015-10-02       Impact factor: 47.728

3.  Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.

Authors:  Chun Jing; Manal Abd El-Ghany; Carol Beesley; Christopher S Foster; Philip S Rudland; Paul Smith; Youqiang Ke
Journal:  J Natl Cancer Inst       Date:  2002-04-03       Impact factor: 13.506

4.  Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Charles P Struzynsky; Sarah E Livings; Brian J Aneskievich
Journal:  Gene       Date:  2012-12-08       Impact factor: 3.688

5.  DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo.

Authors:  Vinita Singh; Tina Branscombe Miranda; Wei Jiang; Adam Frankel; Martha E Roemer; Victoria A Robb; David H Gutmann; Harvey R Herschman; Steven Clarke; Irene F Newsham
Journal:  Oncogene       Date:  2004-10-14       Impact factor: 9.867

6.  Retinaldehyde represses adipogenesis and diet-induced obesity.

Authors:  Ouliana Ziouzenkova; Gabriela Orasanu; Molly Sharlach; Taro E Akiyama; Joel P Berger; Jason Viereck; James A Hamilton; Guangwen Tang; Gregory G Dolnikowski; Silke Vogel; Gregg Duester; Jorge Plutzky
Journal:  Nat Med       Date:  2007-05-27       Impact factor: 53.440

Review 7.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

8.  ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen.

Authors:  Ying-Hui Song; Mei-Zuo Zhong; Ping-Ping Gan; Ping-Yong Yi; You-Hong Tang; Yi-Ping Liu; Jin-Qiong Jiang; Li Li
Journal:  Tumour Biol       Date:  2014-10-25

Review 9.  Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease.

Authors:  Huaibin Cai; Guoxiang Liu; Lixin Sun; Jinhui Ding
Journal:  Transl Neurodegener       Date:  2014-12-10       Impact factor: 8.014

10.  ALDH1A1 provides a source of meiosis-inducing retinoic acid in mouse fetal ovaries.

Authors:  Josephine Bowles; Chun-Wei Feng; Kim Miles; Jessica Ineson; Cassy Spiller; Peter Koopman
Journal:  Nat Commun       Date:  2016-02-19       Impact factor: 14.919

View more
  5 in total

1.  Acinetobacter baumannii Outer Membrane Protein A Induces Pulmonary Epithelial Barrier Dysfunction and Bacterial Translocation Through The TLR2/IQGAP1 Axis.

Authors:  Wang Zhang; Hua Zhou; Yan Jiang; Jintao He; Yue Yao; Jianfeng Wang; Xiaochen Liu; Sebastian Leptihn; Xiaoting Hua; Yunsong Yu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

2.  Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma.

Authors:  Senbang Yao; Wenjun Chen; He Zuo; Ziran Bi; Xiuqing Zhang; Lulian Pang; Yanyan Jing; Xiangxiang Yin; Huaidong Cheng
Journal:  Biochem Genet       Date:  2021-12-20       Impact factor: 2.220

3.  Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.

Authors:  Yu Lei; Ping Han; Yu Chen; Han Wang; Shuhui Wang; Muru Wang; Jingmei Liu; Wei Yan; Dean Tian; Mei Liu
Journal:  Clin Transl Med       Date:  2022-01

4.  Unravelling Mechanisms of Doxorubicin-Induced Toxicity in 3D Human Intestinal Organoids.

Authors:  Daniela Rodrigues; Luke Coyle; Barbara Füzi; Sofia Ferreira; Heeseung Jo; Bram Herpers; Seung-Wook Chung; Ciarán Fisher; Jos C S Kleinjans; Danyel Jennen; Theo M de Kok
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 6.208

5.  Protein arginine methyltransferase 3 inhibits renal tubulointerstitial fibrosis through asymmetric dimethylarginine.

Authors:  Yanzhe Wang; Ming Wu; Feng Yang; Junyan Lin; Li Zhang; Meijie Yuan; Dongping Chen; Bo Tan; Di Huang; Chaoyang Ye
Journal:  Front Med (Lausanne)       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.